Only one study, including non-metastatic node-positive and node-negative patients, showed an association between BRAF mutations and survival in non-metastatic patients, in which the presence of a BRAF mutation predicted worse cancer-free survival (CFS) (Farina-Sarasqueta et al. 2010). The gene discussed is BRAF; the disease is cancer.